Mesothelin-expressing advanced cancers

Clinical trials for Mesothelin-expressing advanced cancers explained in plain language.

Never miss a new study

Get alerted when new Mesothelin-expressing advanced cancers trials appear

Sign up with your email to follow new studies for Mesothelin-expressing advanced cancers, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Terminated 1

New drug CT-95 targets tough cancers in early trial

Disease control Recruiting now

This early-phase study tests a new drug called CT-95 in people with advanced cancers that have a protein called mesothelin on their cells. The main goals are to find a safe dose and see if the drug can shrink tumors. About 70 adults with ovarian, lung, pancreatic, or other mesoth…

Matched conditions: MESOTHELIN-EXPRESSING ADVANCED CANCERS

Phase 1 • Sponsor: Context Therapeutics Inc. • Aim: Disease control

Last updated Jun 27, 2026 13:06 UTC

Mesothelin-expressing advanced cancers

Get alerted when new Mesothelin-expressing advanced cancers trials appear

New drug CT-95 targets tough cancers in early trial